During the last few years, the study of normal bone metabolism and mechanisms of myeloma bone disease has identified several factors that provide novel targets for treating patients with MM bone ...

In a heartfelt moment of sorrow, Prince William finds himself mourning the loss of one of his closest friends, Zach Stubbings ...

Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

Upregulation of cytokines and chemokines is a frequent finding in multiple myeloma (MM ... contribute to the development of bone disease in MM by supporting tumor growth and regulating osteoclast ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.